Medical Technology Stock Letter

BioInvest.com is the web home of the Medical Technology Stock Letter, an industry leading newsletter covering the biotech sector for almost thirty years.  Seeking information on FDA Approvals, Biotech Mergers & Acquisitions, Stock Picks, Long Investments and the occassional Short Sale?  Trying to stay on the cutting edge of scientific developments so you can stay ahead of the Markets? 

The Medical Technology Stock Letter is the source for Biotechnology news and investing advice.  Forget the pundits and the trends.  Here you find only experienced insight and the details that Wall Street doesn't want you to know.

Request a Free Issue then go to the Newsletter page to find out what's new at MTSL.

Subscribers, click here to log in or go directly to the Subscriber area.

Search BioInvest.com
Loading
Latest News from Yahoo! Finance

Jerry Isaacson, Ph.D.

Jerry is a Research Analyst for MTSL and webmaster for BioInvest.com.  He is an experienced biotechnology professional who has worked in various aspects of medicinal chemistry, patents, and investor/public relations.  He has worked for small and mid-size biotech companies in the private and public realms.  He brings a passion for science to his work and will combine that with his deep interest in and knowledge of the biotech industry to constantly try to get at the important, underlying scientific questions that companies may or may not want to have asked.  Jerry holds a Bachelor of Arts degree in Chemistry from Harvard University and received his Ph.D. in Organic Chemistry from the University of California in San Diego.